- Home
- J vs BAX Comparison
J vs BAX Comparison
Compare J & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- J
- BAX
- Stock Information
- Founded
- J 1947
- BAX 1931
- Country
- J United States
- BAX United States
- Employees
- J N/A
- BAX N/A
- Industry
- J Military/Government/Technical
- BAX Medical/Dental Instruments
- Sector
- J Industrials
- BAX Health Care
- Exchange
- J Nasdaq
- BAX Nasdaq
- Market Cap
- J 16.4B
- BAX 15.1B
- IPO Year
- J N/A
- BAX N/A
- Fundamental
- Price
- J $139.22
- BAX $30.97
- Analyst Decision
- J Buy
- BAX Hold
- Analyst Count
- J 11
- BAX 10
- Target Price
- J $156.11
- BAX $40.90
- AVG Volume (30 Days)
- J 650.6K
- BAX 4.9M
- Earning Date
- J 02-04-2025
- BAX 02-06-2025
- Dividend Yield
- J 0.83%
- BAX 3.36%
- EPS Growth
- J 19.27
- BAX N/A
- EPS
- J 6.33
- BAX 0.21
- Revenue
- J $11,500,941,000.00
- BAX $15,062,000,000.00
- Revenue This Year
- J N/A
- BAX N/A
- Revenue Next Year
- J $7.13
- BAX $6.57
- P/E Ratio
- J $29.07
- BAX $130.13
- Revenue Growth
- J 5.99
- BAX 32.37
- 52 Week Low
- J $109.01
- BAX $28.34
- 52 Week High
- J $150.54
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- J 61.84
- BAX 55.98
- Support Level
- J $130.76
- BAX $30.12
- Resistance Level
- J $133.53
- BAX $31.20
- Average True Range (ATR)
- J 2.16
- BAX 0.71
- MACD
- J 0.78
- BAX 0.35
- Stochastic Oscillator
- J 90.58
- BAX 91.96
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $16.4 billion in revenue and $1.3 billion in adjusted operating income in fiscal 2023.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.